Payment overview · 2025
General Payments
$61.12
3 reported records · 3 companies
Healthcare provider profile · identity verified
Amy C Jochims, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · SPENCER, IA · NPI 1013328483
Verified facts
What the public records show
CMS Open Payments records show Amy C Jochims, M.D. received $61.12 in general payments during 2025 across 3 reported records.
Merck Sharp & Dohme LLC accounted for 36.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $22.52 | 36.9% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $22.38 | 36.6% | 1 | 2025 |
| Insulet Corporation | Unresolved — no canonical attribution shown | $16.22 | 26.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $61.12 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CAPVAXIVE Normalized: capvaxive |
Biological | Merck Sharp & Dohme LLC | $22.52 | 1 | 2025 |
Source payment records
|
|||||
| GARDASIL 9 Normalized: gardasil 9 |
Biological | Merck Sharp & Dohme LLC | $22.52 | 1 | 2025 |
Source payment records
|
|||||
| M-M-R II Normalized: m m r ii |
Biological | Merck Sharp & Dohme LLC | $22.52 | 1 | 2025 |
Source payment records
|
|||||
| VAXELIS Normalized: vaxelis |
Biological | Merck Sharp & Dohme LLC | $22.52 | 1 | 2025 |
Source payment records
|
|||||
| VAXNEUVANCE Normalized: vaxneuvance |
Biological | Merck Sharp & Dohme LLC | $22.52 | 1 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $22.38 | 1 | 2025 |
Source payment records
|
|||||
| Omnipod Normalized: omnipod |
Device | Insulet Corporation | $16.22 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 644 | 99 |
| Furosemide | Furosemide | 619 | 73 |
| Omeprazole | Omeprazole | 471 | 73 |
| Metoprolol Succinate | Metoprolol Succinate | 462 | 59 |
| Atorvastatin Calcium | Atorvastatin Calcium | 436 | 102 |
| Lisinopril | Lisinopril | 431 | 74 |
| Sertraline Hcl | Sertraline Hcl | 366 | 43 |
| Amlodipine Besylate | Amlodipine Besylate | 289 | 56 |
| Hydrochlorothiazide | Hydrochlorothiazide | 239 | 48 |
| Eliquis | Apixaban | 231 | 27 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 210 | 42 |
| Losartan Potassium | Losartan Potassium | 207 | 51 |
| Gabapentin | Gabapentin | 191 | 33 |
| Pantoprazole Sodium | Pantoprazole Sodium | 186 | 24 |
| Donepezil Hcl | Donepezil Hcl | 169 | 11 |
| Metoprolol Tartrate | Metoprolol Tartrate | 167 | 28 |
| Memantine Hcl | Memantine Hcl | 165 | 17 |
| Mirtazapine | Mirtazapine | 162 | 16 |
| Metformin Hcl | Metformin Hcl | 159 | 33 |
| Potassium Chloride | Potassium Chloride | 159 | 32 |
| Quetiapine Fumarate | Quetiapine Fumarate | 154 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 130 | 18 |
| Klor-Con M20 | Potassium Chloride | 130 | suppressed |
| Simvastatin | Simvastatin | 129 | 30 |
| Allopurinol | Allopurinol | 125 | 13 |
| Tamsulosin Hcl | Tamsulosin Hcl | 120 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 117 | 27 |
| Tramadol Hcl | Tramadol Hcl | 115 | 26 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 111 | 14 |
| Duloxetine Hcl | Duloxetine Hcl | 111 | 20 |
| Spironolactone | Spironolactone | 107 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 106 | 14 |
| Famotidine | Famotidine | 106 | 15 |
| Clopidogrel | Clopidogrel Bisulfate | 92 | 20 |
| Trazodone Hcl | Trazodone Hcl | 91 | 25 |
| Jardiance | Empagliflozin | 81 | 16 |
| Amitriptyline Hcl | Amitriptyline Hcl | 79 | 16 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 78 | suppressed |
| Klor-Con M10 | Potassium Chloride | 78 | suppressed |
| Ozempic | Semaglutide | 78 | 14 |
| Jantoven | Warfarin Sodium | 77 | suppressed |
| Glipizide Er | Glipizide | 71 | suppressed |
| Meloxicam | Meloxicam | 71 | 19 |
| Prazosin Hcl | Prazosin Hcl | 70 | suppressed |
| Carvedilol | Carvedilol | 69 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 69 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 69 | 11 |
| Risperidone | Risperidone | 63 | suppressed |
| Cephalexin | Cephalexin | 59 | 32 |
| Baclofen | Baclofen | 57 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 56 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 56 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 53 | 11 |
| Benazepril Hcl | Benazepril Hcl | 51 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 51 | suppressed |
| Atenolol | Atenolol | 50 | suppressed |
| Chlorthalidone | Chlorthalidone | 50 | suppressed |
| Levetiracetam | Levetiracetam | 49 | suppressed |
| Mounjaro | Tirzepatide | 48 | suppressed |
| Digoxin | Digoxin | 46 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 46 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 44 | 16 |
| Prednisone | Prednisone | 43 | 16 |
| Buspirone Hcl | Buspirone Hcl | 42 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 41 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 41 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 40 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 40 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 39 | suppressed |
| Hydroxyurea | Hydroxyurea | 38 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 38 | 14 |
| Montelukast Sodium | Montelukast Sodium | 37 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 36 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 32 | suppressed |
| Fenofibrate | Fenofibrate | 30 | suppressed |
| Myrbetriq | Mirabegron | 30 | suppressed |
| Bupropion Xl | Bupropion Hcl | 28 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 27 | suppressed |
| Ezetimibe | Ezetimibe | 27 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 27 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 27 | suppressed |
| Tradjenta | Linagliptin | 27 | suppressed |
| Calcitriol | Calcitriol | 26 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 26 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 26 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 26 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 25 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 24 | 11 |
| Latanoprost | Latanoprost | 24 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 23 | suppressed |
| Levetiracetam Er | Levetiracetam | 23 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 21 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 21 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 21 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 21 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 20 | suppressed |
| Finasteride | Finasteride | 20 | suppressed |
| Januvia | Sitagliptin Phosphate | 20 | suppressed |
| Verapamil Er | Verapamil Hcl | 20 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 19 | suppressed |
| Lidocaine | Lidocaine | 19 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 19 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 19 | suppressed |
| Nystatin | Nystatin | 19 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Xarelto | Rivaroxaban | 19 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 18 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 18 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 18 | suppressed |
| Ondansetron Odt | Ondansetron | 18 | suppressed |
| Irbesartan | Irbesartan | 17 | suppressed |
| Methimazole | Methimazole | 17 | suppressed |
| Methocarbamol | Methocarbamol | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | 13 |
| Olanzapine | Olanzapine | 17 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 17 | suppressed |
| Pregabalin | Pregabalin | 17 | suppressed |
| Carbamazepine | Carbamazepine | 16 | suppressed |
| Ramipril | Ramipril | 16 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 15 | suppressed |
| Sucralfate | Sucralfate | 15 | suppressed |
| Synthroid | Levothyroxine Sodium | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | 13 |
| Estradiol | Estradiol | 14 | suppressed |
| Loperamide | Loperamide Hcl | 14 | suppressed |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Timolol Maleate | Timolol Maleate | 14 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 14 | suppressed |
| Alprazolam | Alprazolam | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 12 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 11 | 11 |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $61.12 · 3 records | Merck Sharp & Dohme LLC | CAPVAXIVE, FREESTYLE LIBRE 3, GARDASIL 9, M-M-R II, Omnipod, VAXELIS, VAXNEUVANCE | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error